Hot Features
プレミアム
Hikma Pharmaceuticals plc (PK) (HKMPY)
USOTC
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a l... Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,400 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. 詳細を表示
Hikma Founder and Honorary Life President Samih Darwazah Passes Away PR Newswire LONDON, May 18, 2015 LONDON, May 18, 2015 /PRNewswire/ -- Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ...
Hikma to Launch Colchicine 0.6mg Capsules PR Newswire LONDON, January 9, 2015 LONDON, January 9, 2015 /PRNewswire/ -- Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK) (OTC:...
Eisai Names Partner For Pan Middle East Distribution of First-in-class Epilepsy Treatment Fycompa® (perampanel) PR Newswire HATFIELD, UK, October 13, 2014 HATFIELD, UK, October 13, 2014...
Unilife Signs Long-Term Supply Agreement with Hikma to Enhance Delivery of Generic Injectables Unilife to receive $40MM in upfront and milestone payments 15-year supply agreement to launch...
Hikma Enters the Moroccan Market Through the Acquisition of 63.9% of Promopharm and Will Launch a Mandatory Tender Offer for the Remaining 36.1% PR Newswire LONDON, October 3, 2011 LONDON...
Hikma CEO Interviewed on Half-Year 2011 Results PR Newswire LONDON, August 25, 2011 LONDON, August 25, 2011 /PRNewswire/ -- Hikma Pharmaceuticals reports lower-than-expected 3.2% increase in...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.79 | 3.67104183757 | 48.76 | 50.55 | 48.76 | 1181 | 49.92778217 | DR |
| 4 | 1.7 | 3.48004094166 | 48.85 | 50.55 | 47.4 | 1029 | 49.73318794 | DR |
| 12 | -2.45 | -4.62264150943 | 53 | 53 | 46.215 | 1154 | 49.72958061 | DR |
| 26 | 2.887 | 6.05710928813 | 47.663 | 55.56 | 46.215 | 853 | 49.85173746 | DR |
| 52 | 1.291 | 2.62084086157 | 49.259 | 55.56 | 46.16 | 921 | 49.75043 | DR |
| 156 | -8.228 | -13.9984347885 | 58.778 | 60 | 25.12 | 1482 | 42.25630123 | DR |
| 260 | 2.8 | 5.86387434555 | 47.75 | 75.81 | 25.12 | 1703 | 48.9443892 | DR |
| 銘柄コード | 株価 | 出来高 |
|---|---|---|
| HMBLHUMBL Inc (PK) | US$ 0.0009 (0.00%) | 359.72M |
| GRLFGreen Leaf Innovations Inc (PK) | US$ 0.00015 (50.00%) | 194.9M |
| AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0.00375 (-1.32%) | 188.36M |
| TSOITherapeutic Solutions International Inc (PK) | US$ 0.0002 (-33.33%) | 168.26M |
| PHILPHI Group Inc (PK) | US$ 0.00025 (-16.67%) | 129.87M |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
